当前位置: X-MOL 学术Lancet › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: a cost-effectiveness analysis of data from the WOMAN trial.
The Lancet ( IF 168.9 ) Pub Date : 2018-02-01 , DOI: 10.1016/s2214-109x(17)30467-9
Bernadette Li 1 , Alec Miners 1 , Haleema Shakur 2 , Ian Roberts 2 ,
Affiliation  

Sub-Saharan Africa and southern Asia account for almost 85% of global maternal deaths from post-partum haemorrhage. Early administration of tranexamic acid, within 3 h of giving birth, was shown to reduce the risk of death due to bleeding in women with post-partum haemorrhage in the World Maternal Antifibrinolytic (WOMAN) trial. We aimed to assess the cost-effectiveness of early administration of tranexamic acid for treatment of post-partum haemorrhage.

中文翻译:

氨甲环酸治疗尼日利亚和巴基斯坦产后出血妇女:对 WOMAN 试验数据的成本效益分析。

撒哈拉以南非洲和南亚几乎占全球产后出血产妇死亡人数的 85%。世界产妇抗纤维蛋白溶解 (WOMAN) 试验显示,在分娩后 3 小时内早期给予氨甲环酸可降低产后出血妇女因出血而死亡的风险。我们旨在评估早期给予氨甲环酸治疗产后出血的成本效益。
更新日期:2018-01-16
down
wechat
bug